Kalpit Patel
Stock Analyst at Wolfe Research
(4.43)
# 1,194
Out of 5,028 analysts
223
Total ratings
38.1%
Success rate
15.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kalpit Patel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RYTM Rhythm Pharmaceuticals | Initiated Coverage: Buy | n/a | $92.45 | - | 1 | Sep 17, 2026 | |
| TSHA Taysha Gene Therapies | Initiated Coverage: Buy | n/a | $4.49 | - | 1 | Sep 17, 2026 | |
| VSTM Verastem | Initiated Coverage: Buy | n/a | $8.00 | - | 8 | Sep 17, 2026 | |
| ZYME Zymeworks | Initiated Coverage: Buy | n/a | $26.21 | - | 1 | Sep 17, 2026 | |
| JANX Janux Therapeutics | Upgraded: Buy | $23 | $16.56 | +38.89% | 1 | Aug 24, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Hold | n/a | $17.27 | - | 1 | Aug 16, 2026 | |
| KRYS Krystal Biotech | Reiterated: Hold | n/a | $334.85 | - | 2 | Aug 11, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $165 → $220 | $207.68 | +5.93% | 2 | Aug 10, 2026 | |
| ONC BeOne Medicines AG | Rated: Buy | $340 → $370 | $361.65 | +2.31% | 5 | Aug 9, 2026 | |
| CORT Corcept Therapeutics | Reiterated: Sell | $50 | $122.03 | -59.03% | 4 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $38.48 | -16.84% | 2 | Jun 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $35 | $23.08 | +51.65% | 1 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $68.71 | - | 2 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $2.58 | +132.56% | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $145 | $81.43 | +78.07% | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $20.93 | - | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $8.25 | - | 1 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $28.46 | n/a | 2 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.76 | n/a | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $38 → $60 | $109.85 | n/a | 13 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $19.00 | n/a | 17 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $28 | $5.85 | n/a | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $14 | $4.01 | n/a | 12 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $6.68 | n/a | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $24 | $47.79 | n/a | 10 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 → $29 | $17.83 | n/a | 9 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.5 → $2 | $1.21 | n/a | 33 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $2.00 | n/a | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $15 | $2.90 | n/a | 5 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $2.34 | n/a | 3 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $1.50 | n/a | 14 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $14 | $1.20 | n/a | 5 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $12.20 | n/a | 6 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $88.04 | n/a | 9 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.42 | n/a | 6 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 9 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.62 | n/a | 10 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $6 | $0.015 | n/a | 5 | Jun 7, 2022 |
Rhythm Pharmaceuticals
Sep 17, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $92.45
Upside: -
Taysha Gene Therapies
Sep 17, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $4.49
Upside: -
Verastem
Sep 17, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $8.00
Upside: -
Zymeworks
Sep 17, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $26.21
Upside: -
Janux Therapeutics
Aug 24, 2026
Upgraded: Buy
Price Target: $23
Current: $16.56
Upside: +38.89%
Summit Therapeutics
Aug 16, 2026
Reiterated: Hold
Price Target: n/a
Current: $17.27
Upside: -
Krystal Biotech
Aug 11, 2026
Reiterated: Hold
Price Target: n/a
Current: $334.85
Upside: -
Revolution Medicines
Aug 10, 2026
Reiterated: Buy
Price Target: $165 → $220
Current: $207.68
Upside: +5.93%
BeOne Medicines AG
Aug 9, 2026
Rated: Buy
Price Target: $340 → $370
Current: $361.65
Upside: +2.31%
Corcept Therapeutics
Jul 29, 2026
Reiterated: Sell
Price Target: $50
Current: $122.03
Upside: -59.03%
Jun 14, 2026
Reiterated: Buy
Price Target: $32
Current: $38.48
Upside: -16.84%
Jun 8, 2026
Upgraded: Buy
Price Target: $35
Current: $23.08
Upside: +51.65%
May 26, 2026
Reiterated: Hold
Price Target: n/a
Current: $68.71
Upside: -
May 19, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $2.58
Upside: +132.56%
May 19, 2026
Initiated Coverage: Buy
Price Target: $145
Current: $81.43
Upside: +78.07%
May 19, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $20.93
Upside: -
Mar 26, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $8.25
Upside: -
Jul 21, 2025
Reiterated: Buy
Price Target: $37
Current: $28.46
Upside: n/a
Jun 16, 2025
Reiterated: Buy
Price Target: $5
Current: $1.76
Upside: n/a
Jun 3, 2025
Upgraded: Buy
Price Target: $38 → $60
Current: $109.85
Upside: n/a
May 21, 2025
Reiterated: Hold
Price Target: $19
Current: $19.00
Upside: n/a
May 7, 2025
Reiterated: Buy
Price Target: $85 → $28
Current: $5.85
Upside: n/a
May 2, 2025
Reiterated: Hold
Price Target: $17 → $14
Current: $4.01
Upside: n/a
Mar 27, 2025
Reiterated: Buy
Price Target: $9
Current: $6.68
Upside: n/a
Mar 5, 2025
Reiterated: Hold
Price Target: $20 → $24
Current: $47.79
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: $36 → $29
Current: $17.83
Upside: n/a
Feb 26, 2025
Downgraded: Hold
Price Target: $3.5 → $2
Current: $1.21
Upside: n/a
Jan 29, 2025
Initiated Coverage: Buy
Price Target: $10
Current: $2.00
Upside: n/a
Nov 18, 2024
Reiterated: Hold
Price Target: $1 → $15
Current: $2.90
Upside: n/a
Sep 27, 2024
Reiterated: Buy
Price Target: $3
Current: $2.34
Upside: n/a
May 14, 2024
Reiterated: Buy
Price Target: $10 → $7
Current: $1.50
Upside: n/a
Aug 14, 2023
Reiterated: Buy
Price Target: $12 → $14
Current: $1.20
Upside: n/a
Mar 21, 2023
Reiterated: Buy
Price Target: $7
Current: $12.20
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $88.04
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.42
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 19, 2022
Rated: Hold
Price Target: n/a
Current: $2.62
Upside: n/a
Jun 7, 2022
Reiterated: Buy
Price Target: $12 → $6
Current: $0.015
Upside: n/a